article thumbnail

Use of Anticoagulant Drug after Aortic Valve Replacement Lowers Mortality Risk, Mayo Clinic Study Finds

DAIC

milla1cf Tue, 12/12/2023 - 07:00 December 12, 2023 — Patients who received the anticoagulant drug warfarin after bioprosthetic aortic valve replacement had lower incidence of mortality and a decreased risk of blood clots, according to a retrospective study published in Mayo Clinic Proceedings.

article thumbnail

Comparing TAVR and SAVR in Medicare Beneficiaries with Aortic Stenosis and Coronary Artery Disease

Society of Thoracic Surgeons - Congenital

Hunter Mehaffey, MD, a cardiothoracic surgeon from West Virginia University, will examine results comparing two treatment options Transcatheter vs. Surgical Aortic Valve Replacement in Medicare Beneficiaries with Aortic Stenosis and Significant Coronary Disease.

article thumbnail

SCAI Scientific Sessions 2025 to Feature Presentations on TAVR, PAD and PE 

DAIC

Washington Convention Center in Washington, DC.

TAVR 52
article thumbnail

Medtronic Presents New Data, Clinical Milestones at CRT 2025

DAIC

Among Medtronic's Structural Heart and Aortic key data milestones,Dr. The presentation addressed the two-year results of the SMall Annuli Randomized To Evolut or SAPIENTrial, which evaluated a valve performance in individuals with aortic stenosiswith small aortic annulusin patients treated with either EvolutTAVR platform or SAPIENplatform.

article thumbnail

Validation of Medicare Advantage Claims for Long-Term Outcome Assessment in Low-Risk Aortic Valve Replacement

Circulation: Cardiovascular Quality & Outcomes

BACKGROUND:Although Medicare Advantage (MA) plans provide coverage to >50% of Medicare beneficiaries, it is unclear whether MA claims can be used similarly to Medicare Fee-For-Service (FFS) claims for clinical outcomes assessment. Circulation: Cardiovascular Quality and Outcomes, Ahead of Print.

article thumbnail

STS Announces Late-breaker Research to Be Presented at the 2024 Annual Meeting

DAIC

The researchers found that Medicare patients undergoing esophagectomy for cancer exhibit identifiable predictors for long-term survival and readmission. These findings suggest opportunities to enhance clinical practice and improve outcomes for Medicare patients undergoing esophagectomy for cancer.

Research 111
article thumbnail

Surgeon Frequency of Aortic Root Enlargement and Long-term Survival in Medicare Beneficiaries Undergoing Surgical Aortic Valve Replacement

The American Journal of Cardiology

Publication date: Available online 9 March 2025 Source: The American Journal of Cardiology Author(s): John Eisenga, Taylor Pickering, Kyle McCullough, Jasjit Banwait, Sarah Hale, Katherine Harrington, William Brinkman, Michael Mack, J. Michael DiMaio, Justin Schaffer